CORD-19:16a812de72963ceda960a168236e8dbe91832d45 / 52719-53060 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T23","span":{"begin":0,"end":341},"obj":"Sentence"}],"text":"In contrast, mice treated with species-and isotype-matched control monoclonal antibody CH12 exhibit fourfold to sixfold less myelin repair, similar to saline treatment; 94.03 and CH12 have greater than 99% amino acid identity, differing only in the third complementarity determining region (CDR3) by five amino acids (Asakura et al., 1998) ."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T265","span":{"begin":0,"end":341},"obj":"Sentence"},{"id":"TextSentencer_T265","span":{"begin":0,"end":341},"obj":"Sentence"},{"id":"T29952","span":{"begin":0,"end":341},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In contrast, mice treated with species-and isotype-matched control monoclonal antibody CH12 exhibit fourfold to sixfold less myelin repair, similar to saline treatment; 94.03 and CH12 have greater than 99% amino acid identity, differing only in the third complementarity determining region (CDR3) by five amino acids (Asakura et al., 1998) ."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T125","span":{"begin":125,"end":131},"obj":"Body_part"}],"attributes":[{"id":"A125","pred":"uberon_id","subj":"T125","obj":"http://purl.obolibrary.org/obo/UBERON_0000345"}],"text":"In contrast, mice treated with species-and isotype-matched control monoclonal antibody CH12 exhibit fourfold to sixfold less myelin repair, similar to saline treatment; 94.03 and CH12 have greater than 99% amino acid identity, differing only in the third complementarity determining region (CDR3) by five amino acids (Asakura et al., 1998) ."}